Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
7.66
-0.14 (-1.79%)
Feb 27, 2026, 4:00 PM EST - Market closed
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $19.41 million as of February 27, 2026. Its market cap has decreased by -39.67% in one year.
Market Cap
19.41M
Enterprise Value
12.46M
1-Year Change
-39.67%
Ranking
Category
Stock Price
$7.66
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $19.41M, a decrease of -70.60%. That is a compound annual growth rate of -36.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 19.41M | -21.22% |
| Dec 31, 2025 | 24.64M | -7.32% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polyrizon | 21.82M |
| NanoViricides | 21.60M |
| VYNE Therapeutics | 19.76M |
| Cadrenal Therapeutics | 19.59M |
| Jupiter Neurosciences | 19.53M |
| Serina Therapeutics | 19.52M |
| Pasithea Therapeutics | 19.34M |
| FibroBiologics | 18.82M |